Efficacy of Low Dose Valganciclovir Prophylaxis for Cytomegalovirus Infection in Kidney Transplantation

Aim:Valganciclovir is the preferred drug for chemoprophylaxis for the prevention of cytomegalovirus (CMV) infection in kidney recipients. Low-dose (450 mg/day) valganciclovir use is gaining popularity because standard dose (900 mg/day) has negative effect on renal function and side effects such as l...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Ümit Özçelik, Nadir Alpay, Eryiğit Eren, Bora Uslu, Ahmet Cem Yardımcı
स्वरूप: लेख
भाषा:English
प्रकाशित: Galenos Yayinevi 2020-01-01
श्रृंखला:Haseki Tıp Bülteni
विषय:
ऑनलाइन पहुंच: http://www.hasekidergisi.com/archives/archive-detail/article-preview/efficacy-of-low-dose-valganciclovir-prophylaxis-fo/35938